Search

everythinglearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

The CTLA-4 gene polymorphism does not affect polycystic ovarian syndrome.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

The gene Tfap2b is essential for creating a type of stem cell in zebrafish that can become different pigment cells.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

CD2 might be a new treatment target for patchy alopecia areata.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

TLR4 is important in aging-related diseases and could be a new treatment target.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Different γδ T cell types have unique roles in causing alopecia areata.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Blocking certain proteins on immune cells may help treat alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

A new neural network helps identify key regulators in cell changes, aiding in understanding diseases and finding new treatments.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

miR-144-y and FOXO3 play key roles in skin and feather development in Zhedong White geese.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.